Controlling DNA–nanoparticle serum interactions

Controlling DNA-nanoparticle serum interactions.

Understanding the interaction of molecularly assembled nanoparticles with physiological fluids is critical to their use for in vivo delivery of drugs and contrast agents. Here, we systematically investigated the factors and mechanisms that govern the degradation of DNA on the nanoparticle surface in serum. We discovered that a higher DNA density, shorter oligonucleotides, and thicker PEG layer ...

Factors Controlling Serum Γ-globulin Concentration

Both synthetic and catabolic processes determine the serum gamma-globulin level. The rate of gamma-globulin synthesis appears to be the primary factor determining the amount of serum gamma-globulin. Increase of gamma-globulin synthesis (as may occur following immunization or development of plasma cell tumor) elevates the serum gamma-globulin level. This, in turn, accelerates the fractional rate...

Noncovalent keystone interactions controlling biomembrane structure.

There is a biomedical need to develop molecular recognition systems that selectively target the interfaces of protein and lipid aggregates in biomembranes. This is an extremely challenging problem in supramolecular chemistry because the biological membrane is a complex dynamic assembly of multifarious molecular components with local inhomogeneity. Two simplifying concepts are presented as a fra...

Controlling chaos in wave-particle interactions.

We analyze the behavior of a relativistic particle moving under the influence of a uniform magnetic field and a stationary electrostatic wave. We work with a set of pulsed waves that allows us to obtain an exact map for the system. We also use a method of control for near-integrable Hamiltonians that consists of the addition of a small and simple control term to the system. This control term cr...

Analysis of Protein Interactions Controlling DNA Methyltransferases